Download PDF
Sprache · Stimme · Gehör 2022; 46(04): 174-180
DOI: 10.1055/a-1941-3571
Schwerpunktthema

Tiefe Hirnstimulation beim idiopathischen Parkinson-Syndrom

Deep Brain Stimulation in Idiopathic Parkinsonʼs Syndrome Patients
Robert Pfister
› Further Information
Also available at
    Permissions and Reprints

Die tiefe Hirnstimulation (THS) kann bei idiopathischem Parkinson-Syndrom (IPS) durch Linderung der motorischen Symptome und Reduktion der Medikamentendosis die Lebensqualität deutlich verbessern. Dieser Beitrag beleuchtet Aspekte der präoperativen Beratung, Operationsplanung und -technik, sowie postoperatives Patient*innenmanagement, Auswirkungen der THS auf Sprechen und Sprache, sowie langfristige Nachbetreuung und Prognose.

Abstract

Deep brain stimulation (DBS) has been approved in Europe for the treatment of idiopathic Parkinson's syndrome (PD) since 1998. Indications for DBS in PD are fluctuations in efficacy with on-off phases and dyskinesia under drug therapy and/or a drug-resistant tremor. Careful determination of the indication and preoperative consultation of the patient are essential for the success of the treatment. DBS improves the quality of life by improving motor symptoms and reducing the dose of medication. Possible side effects of DBS are speech and language disorders, psychological changes and dyskinesia.

Schlüsselwörter

Idiopathisches Parkinson-Syndrom - IPS - tiefe Hirnstimulation - THS - Rigor - Tremor - Dysarthrie

Key Words

idiopathic parkinsonian syndrome - PD - deep brain stimulation - DBS - Rigidity - Tremor - dysarthria


Publication History

Article published online:
29 November 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Krüger R, Klein C. Genetik der Parkinson-Krankheit. Medizin Genet 2013; 25: 215-220
    CrossrefPubMedGoogle Scholar
  • 2 Ascherio A, Schwarzschild MA. The epidemiology of Parkinsonʼs disease: risk factors and prevention. Lancet Neurol 2016; 15: 1257-1272
    CrossrefPubMedGoogle Scholar
  • 3 Postuma RB, Berg D, Stern M. et al. MDS clinical diagnostic criteria for Parkinsonʼs disease. Mov Disord 2015; 30: 1591
    CrossrefPubMedGoogle Scholar
  • 4 Deutsche Gesellschaft für Neurologie (DGN). S3-Leitlinie Idiopathisches Parkinson-Syndrom – Kurzversion. AWMF-Register-Nummer: 030–010. Berlin: 2016
    PubMedGoogle Scholar
  • 5 Santin MDN, Voulleminot P, Vrillon A. et al. Impact of subthalamic deep brain stimulation on impulse control disorders in Parkinson’s disease: A Prospective Study. Mov Disord 2021; 36: 750-757
    CrossrefPubMedGoogle Scholar
  • 6 Schuepbach WM, Rau J, Knudsen K. et al. Neurostimulation for Parkinson’s disease with early motor complications. N Engl J Med 2013; 368: 610-622
    CrossrefPubMedGoogle Scholar
  • 7 Shih LC, Tarsy D. Deep brain stimulation for the treatment of atypical parkinsonism. Mov Disord 2007; 22: 2149-2155
    CrossrefPubMedGoogle Scholar
  • 8 Deep-Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med 2001; 345: 956-963
    CrossrefPubMedGoogle Scholar
  • 9 Bunjo Z, Bacchi S, Chandran AS. et al. Orthostatic hypotension following deep brain stimulation in Parkinson’s disease: a systematic review. Br J Neurosurg 2020; 34: 587-590
    CrossrefPubMedGoogle Scholar
  • 10 Zong H, Meng F, Zhang Y. et al. Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson’s disease. Clin Interv Aging 2019; 14: 1159-1166
    CrossrefPubMedGoogle Scholar
  • 11 Bjerknes S, Skogseid IM, Hauge TJ. et al. Subthalamic deep brain stimulation improves sleep and excessive sweating in Parkinson’s disease. NPJ Parkinsons Dis 2020; 6: 29
    CrossrefPubMedGoogle Scholar
  • 12 Tanaka Y, Tsuboi T, Watanabe H. et al. Longitudinal speech change after subthalamic nucleus deep brain stimulation in Parkinsonʼs disease patients: a 2-year prospective study. J Parkinsons Dis 2020; 10 : 131-140 DOI: 10.3233/JPD-191798.
    CrossrefPubMedGoogle Scholar
  • 13 Karlsson F, Malinova E, Olofsson K. et al. Voice tremor outcomes of subthalamic nucleus and zona incerta deep brain stimulation in patients with Parkinson disease. J Voice 2019; 33 : 545-549 DOI: 10.1016/j.jvoice.2017.12.012.
    CrossrefPubMedGoogle Scholar
  • 14 Leimbach F, Atkinson-Clement C, Wilkinson L. et al. Dissociable effects of subthalamic nucleus deep brain stimulation surgery and acute stimulation on verbal fluency in Parkinsonʼs disease. Behav Brain Res 2020; 388: 112621 DOI: 10.1016/j.bbr.2020.112621.
    CrossrefPubMedGoogle Scholar
  • 15 Kluin KJ, Mossner JM, Costello JT. et al. Motor speech effects in subthalamic deep brain stimulation for Parkinsonʼs disease. J Neurosurg 2022; 28: 1-7 DOI: 10.3171/2021.12.JNS211729.
    CrossrefPubMedGoogle Scholar
  • 16 Demmel W, Pfister R. Tiefe Hirnstimulation beim idiopathischen Parkinson-Syndrom - Planung, operatives Vorgehen und Risiken. Nervenheilkunde 2021; 40: 794-801
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Montaurier C, Morio B, Bannier S. et al. Mechanisms of body weight gain in patients with Parkinsonʼs disease after subthalamic stimulation. Brain 2007; 130 : 1808-1818 DOI: 10.1093/brain/awm113.
    CrossrefPubMedGoogle Scholar
  • 18 Dembek TA, Reker P, Visser-Vandewalle V. et al. Directional DBS increases side-effect thresholds-A prospective, double-blind trial. Mov Disord 2017; 32 : 1380-1388 DOI: 10.1002/mds.27093.
    CrossrefPubMedGoogle Scholar
  • 19 Van Lancker Sidtis D, Rogers T, Godier V. et al. Voice and fluency changes as a function of speech task and deep brain stimulation. J Speech Lang Hear Res 2010; 53 : 1167-1177 DOI: 10.1044/1092-4388(2010/09-0154).
    CrossrefPubMedGoogle Scholar
  • 20 Wyman-Chick KA. Verbal Fluency in Parkinsonʼs Patients with and without Bilateral Deep Brain Stimulation of the Subthalamic Nucleus: A Meta-analysis. J Int Neuropsychol Soc 2016; 22 : 478-485 DOI: 10.1017/S1355617716000035.
    CrossrefPubMedGoogle Scholar
  • 21 Ehlen F, Krugel LK, Vonberg I. et al. Intact lexicon running slowly – prolonged response latencies in patients with subthalamic DBS and verbal fluency deficits. PLoS One 2013; 8 : e79247 DOI: 10.1371/journal.pone.0079247.
    CrossrefPubMedGoogle Scholar
  • 22 Leimbach F, Atkinson-Clement C, Wilkinson L. et al. Dissociable effects of subthalamic nucleus deep brain stimulation surgery and acute stimulation on verbal fluency in Parkinsonʼs disease. Behav Brain Res 2020; 388: 112621 DOI: 10.1016/j.bbr.2020.112621.
    CrossrefPubMedGoogle Scholar
  • 23 Vos SH, Kessels RPC, Vinke RS. et al. The Effect of Deep Brain Stimulation of the Subthalamic Nucleus on Language Function in Parkinsonʼs Disease: A Systematic Review. J Speech Lang Hear Res 2021; 64 : 2794-2810 DOI: 10.1044/2021_JSLHR-20-00515.
    CrossrefPubMedGoogle Scholar
  • 24 Le Goff F, Derrey S, Lefaucheur R. et al. Decline in verbal fluency after subthalamic nucleus deep brain stimulation in Parkinsonʼs disease: a microlesion effect of the electrode trajectory?. J Parkinsons Dis 2015; 5 : 95-104 DOI: 10.3233/JPD-140443.
    CrossrefPubMedGoogle Scholar
  • 25 Fenoy AJ, McHenry MA, Schiess MC. Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract. J Neurosurg 2017; 126 : 2017-2027 DOI: 10.3171/2016.5.JNS16243.
    CrossrefPubMedGoogle Scholar
  • 26 Greif TR, Askari A, Cook Maher A. et al. Anterior lead location predicts verbal fluency decline following STN-DBS in Parkinsonʼs disease. Parkinsonism Relat Disord 2021; 92: 36-40 DOI: 10.1016/j.parkreldis.2021.10.012.
    CrossrefPubMedGoogle Scholar
  • 27 Grover T, Georgiev D, Kalliola R. et al. Effect of Low versus High Frequency Subthalamic Deep Brain Stimulation on Speech Intelligibility and Verbal Fluency in Parkinsonʼs Disease: A Double-Blind Study. J Parkinsons Dis 2019; 9 : 141-151 DOI: 10.3233/JPD-181368.
    CrossrefPubMedGoogle Scholar
  • 28 Limousin P, Foltynie T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol 2019; 15: 234-242
    CrossrefPubMedGoogle Scholar
  • 29 Weiss D, Wächter T, Breit S. et al. Involuntary eyelid closure after STN-DBS: evidence for different pathophysiological entities. J Neurol Neurosurg Psychiatry 2010; 81: 1002-1007
    CrossrefPubMedGoogle Scholar
  • 30 Bangash OK, Thorburn M, Garcia-Vega J. et al. Drowning hazard with deep brain stimulation: case report. J Neurosurg 2016; 124: 1513-1516
    CrossrefPubMedGoogle Scholar
  • 31 Reuter S, Deuschl G, Falk D. et al. Uncoupling of dopaminergic and subthalamic stimulation: life-threatening DBS withdrawal syndrome. Mov Disord 2015; 30: 1407-1413
    CrossrefPubMedGoogle Scholar